Global Subcutaneous Immunoglobulins Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 23, 2020  |  211 PAGES  |  REPORT CODE: CMM377288
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

Subcutaneous injection of immune proteins is well tolerated and safe, and is clinically suitable for all patients. Subcutaneous immunoglobulin is superior to intravenous immunoglobulin because it does not require intravenous access and reduces the need for prodrug therapy with glucocorticoids and antihistamines. Due to the reduction of global market participants and the time interval between plasma collection and product launch, the production of subcutaneous immunoglobulin becomes cumbersome and time-consuming, and if not managed properly, it will hinder the subcutaneous immunoglobulin market during the forecast period.

In July 2019, Grifols announced that Xembify has been approved by the US Food and Drug Administration. This is a new 20% subcutaneous immunoglobulin product for the treatment of patients with idiopathic immunodeficiency 2 years and older.

The increase in the incidence of autoimmune diseases will help drive the growth of this market during the forecast period. The deepening of the aging population has led to an increase in the infectivity of the elderly population, and the prevalence of several diseases such as cancer, diabetes and neurological diseases is rising, which has driven the global demand for subcutaneous immunoglobulin market.

The Subcutaneous Immunoglobulins is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period. The research provides insights for the global Subcutaneous Immunoglobulins market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Subcutaneous Immunoglobulins industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Subcutaneous Immunoglobulins Market Segmentations:

By Players:

  • Shire (Baxalta)

  • Grifols

  • CSL

By Types:

  • 10% Purity

  • 20% Purity

By End-User:

  • Primary Immunodeficiency

  • Secondary Immunodeficiency

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Subcutaneous Immunoglobulins Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Subcutaneous Immunoglobulins Market Size and Growth Rate of 10% Purity from 2014 to 2026

    • 1.3.2 Global Subcutaneous Immunoglobulins Market Size and Growth Rate of 20% Purity from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Primary Immunodeficiency from 2014 to 2026

    • 1.4.2 Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Secondary Immunodeficiency from 2014 to 2026

    • 1.4.3 Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Subcutaneous Immunoglobulins Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Subcutaneous Immunoglobulins Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Subcutaneous Immunoglobulins by Major Types

    • 3.4.1 Subcutaneous Immunoglobulins Market Size and Growth Rate of 10% Purity

    • 3.4.2 Subcutaneous Immunoglobulins Market Size and Growth Rate of 20% Purity

4 Segmentation of Subcutaneous Immunoglobulins Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Subcutaneous Immunoglobulins by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Subcutaneous Immunoglobulins in Primary Immunodeficiency

    • 4.4.2 Market Size and Growth Rate of Subcutaneous Immunoglobulins in Secondary Immunodeficiency

    • 4.4.3 Market Size and Growth Rate of Subcutaneous Immunoglobulins in Others

5 Market Analysis by Major Regions

  • 5.1 Global Subcutaneous Immunoglobulins Production Analysis by Major Regions

  • 5.2 Global Subcutaneous Immunoglobulins Consumption Analysis by Major Regions

  • 5.3 Global Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis

6 Product Commodity of Subcutaneous Immunoglobulins Market in Major Countries

  • 6.1 Top 5 Export Countries in Subcutaneous Immunoglobulins market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Subcutaneous Immunoglobulins market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Subcutaneous Immunoglobulins Landscape Analysis

  • 7.1 North America Subcutaneous Immunoglobulins Landscape Analysis by Major Types

  • 7.2 North America Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users

  • 7.3 North America Subcutaneous Immunoglobulins Landscape Analysis by Major Countries

    • 7.3.1 United States Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 7.3.2 Canada Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 7.3.3 Mexico Subcutaneous Immunoglobulins Market Volume and Growth Rate

8 Europe Subcutaneous Immunoglobulins Landscape Analysis

  • 8.1 Europe Subcutaneous Immunoglobulins Landscape Analysis by Major Types

  • 8.2 Europe Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users

  • 8.3 Europe Subcutaneous Immunoglobulins Landscape Analysis by Major Countries

    • 8.3.1 Germany Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.2 UK Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.3 France Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.4 Italy Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.6 Spain Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.7 Belgium Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.8 Poland Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.9 Russia Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 8.3.10 Turkey Subcutaneous Immunoglobulins Market Volume and Growth Rate

9 Asia Pacific Subcutaneous Immunoglobulins Landscape Analysis

  • 9.1 Asia Pacific Subcutaneous Immunoglobulins Landscape Analysis by Major Types

  • 9.2 Asia Pacific Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Subcutaneous Immunoglobulins Landscape Analysis by Major Countries

    • 9.3.1 China Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 9.3.2 Japan Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 9.3.4 India Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 9.3.6 South Korea Subcutaneous Immunoglobulins Market Volume and Growth Rate

10 Latin America, Middle East & Africa Subcutaneous Immunoglobulins Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Subcutaneous Immunoglobulins Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Subcutaneous Immunoglobulins Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Subcutaneous Immunoglobulins Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 10.3.2 Brazil Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 10.3.3 Nigeria Subcutaneous Immunoglobulins Market Volume and Growth Rate

    • 10.3.4 South Africa Subcutaneous Immunoglobulins Market Volume and Growth Rate 

    • 10.3.5 Argentina Subcutaneous Immunoglobulins Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Shire (Baxalta)

    • 11.1.1 Shire (Baxalta) Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Grifols

    • 11.2.1 Grifols Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 CSL

    • 11.3.1 CSL Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 110 Figures and 180 Tables)

  • Figure Product Picture

  • Figure Subcutaneous Immunoglobulins Market Size and Growth Rate of 10% Purity from 2014 to 2026

  • Figure Subcutaneous Immunoglobulins Market Size and Growth Rate of 20% Purity from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Primary Immunodeficiency from 2014 to 2026

  • Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Secondary Immunodeficiency from 2014 to 2026

  • Figure Global Subcutaneous Immunoglobulins Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Subcutaneous Immunoglobulins Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Subcutaneous Immunoglobulins Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Subcutaneous Immunoglobulins

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Subcutaneous Immunoglobulins by Different Types from 2014 to 2026

  • Table Consumption Share of Subcutaneous Immunoglobulins by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of 10% Purity

  • Figure Market Size and Growth Rate of 20% Purity

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Subcutaneous Immunoglobulins by Different End-Users from 2014 to 2026

  • Table Consumption Share of Subcutaneous Immunoglobulins by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Primary Immunodeficiency

  • Figure Market Size and Growth Rate of Secondary Immunodeficiency

  • Figure Market Size and Growth Rate of Others

  • Table Global Subcutaneous Immunoglobulins Production by Major Regions

  • Table Global Subcutaneous Immunoglobulins Production Share by Major Regions

  • Figure Global Subcutaneous Immunoglobulins Production Share by Major Regions in 2014

  • Figure Global Subcutaneous Immunoglobulins Production Share by Major Regions in 2018

  • Figure Global Subcutaneous Immunoglobulins Production Share by Major Regions in 2026

  • Table Global Subcutaneous Immunoglobulins Consumption by Major Regions

  • Table Global Subcutaneous Immunoglobulins Consumption Share by Major Regions

  • Figure Global Subcutaneous Immunoglobulins Consumption Share by Major Regions in 2014

  • Figure Global Subcutaneous Immunoglobulins Consumption Share by Major Regions in 2018

  • Figure Global Subcutaneous Immunoglobulins Consumption Share by Major Regions in 2026

  • Table North America Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis

  • Table Europe Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Subcutaneous Immunoglobulins Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Subcutaneous Immunoglobulins market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Subcutaneous Immunoglobulins Consumption by Types from 2014 to 2026

  • Table North America Subcutaneous Immunoglobulins Consumption Share by Types from 2014 to 2026

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by Types in 2014

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by Types in 2018

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by Types in 2026

  • Table North America Subcutaneous Immunoglobulins Consumption by End-Users from 2014 to 2026

  • Table North America Subcutaneous Immunoglobulins Consumption Share by End-Users from 2014 to 2026

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by End-Users in 2014

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by End-Users in 2018

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by End-Users in 2026

  • Table North America Subcutaneous Immunoglobulins Consumption by Major Countries from 2014 to 2026

  • Table North America Subcutaneous Immunoglobulins Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2014

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2018

  • Figure North America Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2026

  • Figure United States Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Subcutaneous Immunoglobulins Consumption by Types from 2014 to 2026

  • Table Europe Subcutaneous Immunoglobulins Consumption Share by Types from 2014 to 2026

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by Types in 2014

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by Types in 2018

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by Types in 2026

  • Table Europe Subcutaneous Immunoglobulins Consumption by End-Users from 2014 to 2026

  • Table Europe Subcutaneous Immunoglobulins Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by End-Users in 2014

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by End-Users in 2018

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by End-Users in 2026

  • Table Europe Subcutaneous Immunoglobulins Consumption by Major Countries from 2014 to 2026

  • Table Europe Subcutaneous Immunoglobulins Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2014

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2018

  • Figure Europe Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2026

  • Figure Germany Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure France Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Subcutaneous Immunoglobulins Consumption by Types from 2014 to 2026

  • Table Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Types in 2014

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Types in 2018

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Types in 2026

  • Table Asia Pacific Subcutaneous Immunoglobulins Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Subcutaneous Immunoglobulins Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by End-Users in 2014

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by End-Users in 2018

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by End-Users in 2026

  • Table Asia Pacific Subcutaneous Immunoglobulins Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2026

  • Figure China Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandSubcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure India Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Subcutaneous Immunoglobulins Consumption Share by Major Countries in 2026

  • Figure GCC Countries Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Subcutaneous Immunoglobulins Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Shire (Baxalta)

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire (Baxalta)

  • Figure Sales and Growth Rate Analysis of Shire (Baxalta)

  • Figure Revenue and Market Share Analysis of Shire (Baxalta)

  • Table Product and Service Introduction of Shire (Baxalta)

  • Table Company Profile and Development Status of Grifols

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

  • Figure Sales and Growth Rate Analysis of Grifols

  • Figure Revenue and Market Share Analysis of Grifols

  • Table Product and Service Introduction of Grifols

  • Table Company Profile and Development Status of CSL

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

  • Figure Sales and Growth Rate Analysis of CSL

  • Figure Revenue and Market Share Analysis of CSL

  • Table Product and Service Introduction of CSL


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top